ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Crestchem Ltd promoters reported market transactions on September 10, 2026. Director Dipak Patel acquired 981 shares while Sonalben Patel sold 1,000 shares.
Promoter Dipak Narendraprasad Patel acquired 200 equity shares of Crestchem Ltd via market purchase for ₹0.0026 Crore.
Crestchem Limited issued duplicate share certificates to one shareholder for three lost certificates covering 100 shares. This is a routine administrative filing with no financial impact.
Promoter Sonal Dushyant Patel sold 2,042 shares of Crestchem Ltd via a market sale. The transaction proceeds were ₹0.03 Crore.
Promoter Sonalben Dushyantbhai Patel sold 700 shares of Crestchem Ltd via market sale on BSE. The transaction value is approximately ₹0.01 Crore.
Promoter Dipak Narendraprasad Patel bought 981 shares for ₹0.01 Crore, while Promoter Sonalben Dushyantbhai Patel sold 1,000 shares for ₹0.01 Crore on the open market.
Promoter Dipak Narendraprasad Patel acquired 200 equity shares of Crestchem Ltd via market purchase on September 9, 2026.
Promoter and Director Dipak Narendraprasad Patel acquired 200 equity shares of Crestchem Ltd through market purchase on September 9, 2026.
Crestchem Limited has appointed Mr. Indrajyotsingh Ranjitsingh Bagga as the new Compliance Officer and Assistant Company Secretary, effective September 8, 2026.
Crestchem Limited has scheduled a board meeting for September 8, 2026. The board will consider the appointment of Indrajyot Bagga as Assistant Company Secretary.
Promoter Dipak Narendraprasad Patel acquired 437 shares of Crestchem Ltd for ₹0.01 Crore via market purchase. His stake increased marginally to 29.64%.
Promoter and Director Dipak Narendraprasad Patel acquired 120 equity shares of Crestchem Ltd through market purchase on August 25, 2026.
Crestchem Ltd filed its quarterly shareholding pattern as of December 31, 2025. This document provides a standard breakdown of promoter and public shareholdings.
Crestchem Ltd reported revenue from operations of ₹9.2 Cr (+84.0% YoY) and net profit of ₹1 Cr (+233.3% YoY) for Q1 FY27.
Crestchem Ltd has scheduled a board meeting for August 12, 2026. The board will consider Q1 FY26 financial results and a BSE-imposed fine.
Crestchem Limited conducted its 34th Annual General Meeting on August 6, 2026, via video conferencing. The meeting concluded with remote and meeting-day e-voting results pending formal declaration.
Crestchem Limited disclosed a BSE fine of ₹1.06 Lakh for late submission of a consolidated cash flow statement. The company expects a waiver of this fine.
Crestchem Limited declared a dividend of Rs. 1.50 per equity share for FY 2025-26. The record date is fixed for July 30, 2026.
Crestchem Limited scheduled its 34th AGM for August 6, 2026. The company declared a dividend of Rs.1.50 per share totaling Rs.0.45 Crore.
Crestchem Limited submitted its 34th Annual Report for FY 2025-26. The company reported a total income of Rs. 25.52 Crore and net profit of Rs. 2.71 Crore.
Crestchem Limited has scheduled a board meeting for July 4, 2026. The meeting will address other business matters and trading window closure.
Crestchem Ltd's board approved AGM notice, reports, and dividend account. No financial results or dividend amount declared in this outcome.
Crestchem Ltd scheduled a board meeting for July 04, 2026. The meeting will consider the 34th AGM and other corporate matters.
Promoter Sonal Dushyant Patel sold 14,600 Crestchem shares for ₹1.30 million (≈₹0.13 Cr) via the open market. The transaction reduces the promoter’s holding by about 0.48%.
Crestchem Ltd reported revenue from operations of ₹10.2 Cr (+41.7% YoY) and net profit of ₹1.1 Cr (+83.3% YoY) for Q4 FY26.
Crestchem Limited reported audited FY26 results and recommended a 15% final dividend. It also approved a ₹2.25 Crore investment into its newly formed subsidiary.
Crestchem Limited scheduled a board meeting on May 26, 2026, to approve annual results and final dividend. It also considers a ₹2.25 Crore subsidiary investment.
Crestchem Limited confirms non-applicability of Regulation 24A secretarial reporting for fiscal 2026. The company remains below regulatory thresholds for mandatory compliance filings.
Crestchem Limited announced its subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED (75% stake), has commenced operations after completing RoC filings. The new entity will manufacture speciality oleo chemicals, with a pilot plant being established in Bangalore.
Crestchem Ltd's board approved the formation of a new subsidiary, Oleo Bioscienses Private Limited, in Bangalore with a ₹0.1 Crore capital. The company acquired a 75% stake for ₹7.5 Lakhs to establish manufacturing and development facilities. The board is currently re-evaluating the project due to global uncertainties while day-to-day operations are vested with local management.